Kidney Cancer Weekly

August 19, 2024

Videos

Peer-to-Peer Clinical Conversations

Advancing RCC Treatment: PROSPER Trial Analysis and Future Directions - Naomi Haas

Naomi Haas

Naomi Haas discusses the PROSPER trial, a study exploring perioperative nivolumab in high-risk renal cell carcinoma (RCC).

Update on Biomarkers in Renal Cell Carcinoma - David Braun

David Braun

Pedro Barata and David Braun delve into the evolving landscape of biomarkers in renal cell carcinoma (RCC).

Beyond the Abstracts

Patient's Self-Reported Quality of Life as a Prognostic Factor in Metastatic Renal Cell Carcinoma Initially Treated with TKI: Nomogram Proposal - Beyond the Abstract

Long-Term Functional Outcomes in Patients Undergoing Radical Nephrectomy for Renal Cell Carcinoma and Tumor Thrombus - Beyond the Abstract

Conference Coverage

ASCO 2024: Comparison of TKI and CPI Strategies as First-Line Treatment of Patients with Advanced Renal Cell Carcinoma: Real-World Outcome Data from the German Research Platform CARAT

AUA 2024: Tumor Size Reduction (≥10% ) Resulting from Pre-Surgical Systemic Therapy Predicts Improved Survival Following Cytoreductive Nephrectomy

SESAUA 2024: Safety and Efficacy of Surgery in Metastatic and Non-Metastatic RCC with Supradiaphragmatic Tumor Thrombus Involving Cardiac Procedures

ASCO GU 2024: Genetic Testing in RCC: Who, When, and How?

Articles

Editor Selected Abstracts and Commentaries

Renal Cancer

Prognostic impact and genomic backgrounds of renal parenchymal infiltration or micronodular spread in non-metastatic clear cell renal cell carcinoma.

Polygenic score for body mass index in relation to mortality among patients with renal cell cancer.

External validation of the ability of the mRENAL nephrometry score to identify patients at risk for major adverse events or local tumor recurrence after percutaneous renal cryoablation.

Mitochondrial complex I promotes kidney cancer metastasis.

Transcriptome- and proteome-wide association studies identify genes associated with renal cell carcinoma.

Nc-RNA-mediated low expression of AZIN1 correlated with unfavorable prognosis in kidney renal clear cell carcinoma.

Optimal sequential therapy using tyrosine kinase inhibitors as the first-line treatment in patients with metastatic renal cell carcinoma: A nationwide multicenter study.

Evaluation of American Urological Association Renal Cell Carcinoma Risk Groups for Chromophobe Renal Cell Carcinoma.

Renal Function Preservation in Purely Off-Clamp Sutureless Robotic Partial Nephrectomy: Initial Experience and Technique.

Cost trends of Metastatic Renal Cell Carcinoma Therapy: the impact of oral anticancer agents and immunotherapy.

Baseline neutrophil-to-eosinophil-ratio and outcome in metastatic clear-cell renal cell carcinoma treated with nivolumab or ipilimumab/nivolumab.

CONNECT WITH US

Questions or Comments? Email us at editors@urotoday.com

Digital Science Press, LLC
2011 Phaethon Lane,
Reno, NV 89523

You are receiving this email because you have chosen to receive emails from UroToday.

Add us to your address book View this email as a web page Forward to a colleague Manage your subscriptions Unsubscribe

Copyright ©2024 Digital Science Press, LLC